May 25, 2026

Qiagen N.V. (QGEN) Stock Analysis: Evaluating the 24.59% Potential Upside

Qiagen N.V. (NYSE: QGEN), a prominent player in the healthcare sector specializing in diagnostics and research, has recently captured the attention of investors, not least due to its significant growth..

Glaukos Corporation (GKOS) Stock Analysis: Exploring a 28.5% Potential Upside with a Strong Buy Consensus

Glaukos Corporation (NYSE: GKOS), a prominent player in the healthcare sector specializing in medical devices, particularly ophthalmic pharmaceuticals, is capturing investor attention with its robust growth prospects and substantial potential..

TransMedics Group, Inc. (TMDX) Stock Analysis: Unveiling a 71% Potential Upside in the Medical Device Sector

For investors with an appetite for breakthrough medical technologies, TransMedics Group, Inc. (TMDX) presents a compelling opportunity in the healthcare sector. Based in Andover, Massachusetts, TransMedics is pioneering the transformation..

Natera, Inc. (NTRA) Stock Analysis: Riding High on a 28.4% Potential Upside

Natera, Inc. (NASDAQ: NTRA), a prominent player in the healthcare sector, particularly in diagnostics and research, is capturing investor attention with its impressive market capitalization of $29.1 billion. Despite a..

Haleon plc (HLN) Stock Analysis: Exploring a 26% Potential Upside in the Healthcare Sector

Haleon plc (HLN), a stalwart in the healthcare sector, currently presents a compelling opportunity for investors seeking growth potential and stability. Positioned in the Drug Manufacturers – Specialty & Generic..

Regencell Bioscience Holdings (RGC) Stock Analysis: Is This Hong Kong Healthcare Player Set for a Breakthrough?

Regencell Bioscience Holdings Limited (NASDAQ: RGC) has emerged as a notable player in the healthcare sector, specifically within the niche of Traditional Chinese Medicine (TCM) focused on neurocognitive disorders. With..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Exploring a 55% Upside Potential

iRhythm Holdings, Inc. (NASDAQ: IRTC) stands as a promising entity within the healthcare sector, specifically in the medical devices industry. With a market capitalization of $3.83 billion, this San Francisco-based..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Unveiling a Potential 18.99% Upside in the Healthcare Sector

Inspire Medical Systems, Inc. (NASDAQ: INSP), a prominent player in the healthcare sector, specializes in medical devices that address obstructive sleep apnea (OSA), a condition affecting millions globally. Headquartered in..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Unveiling a Promising 22.8% Potential Upside

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biopharmaceutical innovator, is capturing investor attention with a potential upside of 22.8%, as indicated by its current average target price of $83.90. Operating within..

Gilead Sciences (GILD) Stock Analysis: Understanding the 17.47% Potential Upside for Investors

Gilead Sciences, Inc. (NASDAQ: GILD), a stalwart in the healthcare sector, continues to capture investor attention with its robust portfolio in the biopharmaceutical space. The Foster City-based company, with a..

Vertex Pharmaceuticals (VRTX) Stock Analysis: A Biotech Powerhouse with 26% Upside Potential

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a formidable player within the biotechnology sector, boasting a market capitalization of $110.28 billion. With a focus on developing transformative medicines for serious..

Veeva Systems Inc. (VEEV) Stock Analysis: Exploring a 64% Potential Upside

Veeva Systems Inc. (NYSE: VEEV), a leader in providing cloud-based solutions for the life sciences industry, is attracting investor attention with its strong growth potential. With a market capitalization of..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A 49.88% Potential Upside for Biotech Investors

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leader in the biotechnology sector, is catching the eye of investors with its substantial market capitalization of $39.71 billion. Headquartered in Cambridge, Massachusetts, Alnylam..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a 23% Potential Upside in the Biotech Sector

TG Therapeutics, Inc. (NASDAQ: TGTX), a prominent player in the biotechnology sector, is garnering attention from investors with its promising financial outlook and strategic focus on innovative treatments for B-cell..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Exploring a Potential 41.24% Upside

Merit Medical Systems, Inc. (NASDAQ: MMSI), a prominent player in the healthcare sector, has garnered significant attention from investors due to its robust product offerings and promising growth potential. Specializing..

RadNet, Inc. (RDNT) Stock Analysis: Unveiling a 65% Potential Upside with Strong Buy Ratings

RadNet, Inc. (NASDAQ: RDNT) has emerged as a compelling candidate for investors seeking exposure in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of..

Zoetis Inc. (ZTS) Stock Analysis: Exploring a 53% Potential Upside in the Animal Health Leader

Zoetis Inc. (NYSE: ZTS), a prominent player in the healthcare sector, continues to captivate investor attention with its strategic positioning in the animal health industry. As a leader in the..

Insulet Corporation (PODD) Stock Analysis: Navigating a 59% Potential Upside in the Medical Device Sector

Investors with a keen eye on the healthcare sector may find Insulet Corporation (NASDAQ: PODD) an intriguing opportunity, especially given its significant potential upside. The company, known for its innovative..

BridgeBio Pharma, Inc. (BBIO) Growth Potential: Analyst Ratings Signal 47% Upside

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a biopharmaceutical firm headquartered in Palo Alto, California, is making waves in the biotechnology sector with its innovative approach to treating genetic diseases. With a..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Exploring a 23.98% Upside Potential

GE HealthCare Technologies Inc. (NYSE: GEHC) stands as a formidable player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $29.22 billion, GE HealthCare..

Search

Funds

May 25, 2026

Search

Funds

May 25, 2026

FTSE 100

Funds